Russia's Vector Launches Production of EpiVacCorona Vaccine Against COVID-19, Watchdog Says

MOSCOW (Sputnik) - Russia's research centre Vector has already launched production of its coronavirus vaccine EpiVacCorona, the head of the national public health watchdog, Anna Popova, said on Tuesday. "Vector has started production of the vaccine", Popova said at a healthcare forum. A certain number of EpiVacCorona doses will be produced by the end of the year, the official specified. There are 10 technological platforms for developing vaccines against COVID-19 globally, Vector's deputy chief for scientific work Elena Gavrilova said at a healthcare forum. "We use six technological platforms for developing vaccines against the novel coronavirus in our centre", she added. Russia has registered 16,550 COVID-19 cases in the past 24 hours, down from yesterday's record-high 17,347, taking the cumulative total to 1,547,774, the country's coronavirus response centre said earlier today. In August, Russia became the first country in the world to register a vaccine against the coronavirus, dubbed Sputnik V and developed by the Gamaleya research institute. In mid-October, Russian President Vladimir Putin announced that the second vaccine, Vector's EpiVacCorona, had been registered. Read more: https://sputniknews.com/russia/202010271080888855-russias-vector-launches-production-of-epivaccorona/